Lucosky Brookman Represents WestPark Capital in Shuttle Pharmaceuticals' $5.75 Million Public Offering
Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on…
Read MoreLucosky Brookman is a leader in the representation of small and micro-cap companies. The Firm has led it clients through numerous capital raise transaction and over a dozen uplisting and initial public offering transactions. Access the latest news about Lucosky Brookman, our clients’ business transactions and industry updates here.
Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on…
Read MoreBrag House Holdings, Inc. (NASDAQ: BRAG), a pioneering media technology platform revolutionizing the casual college gaming experience,…
Read MoreCapstone Holding Corp. (NASDAQ: CAPS), a pioneering building products distribution company revolutionizing the construction materials sector,…
Read MoreHeartBeam, Inc. (NASDAQ: BEAT), a pioneering medical technology company revolutionizing cardiac care, has closed its $10 million public…
Read MoreIn a significant transaction for the biotechnology sector, Belite Bio, Inc (NASDAQ: BLTE) has secured $15 million through a registered…
Read MoreATIF Holdings Limited (NASDAQ: ZBAI), a Lake Forest-based business consulting firm specializing in IPO and M&A advisory services, has…
Read MoreIn a pivotal development for the pain management sector, Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) has successfully raised $6 million through…
Read MoreQuantum Computing Inc. (NASDAQ: QUBT), an innovative integrated photonics and quantum optics technology company, has successfully closed a…
Read MoreDatChat, Inc. (NASDAQ: DATS), a secure messaging, social media, and metaverse company, has successfully closed a $5.1 million registered…
Read MoreWOODBRIDGE, N.J., January 10, 2025 /PRNewswire/ -- Lucosky Brookman LLP, a leading entrepreneurial and business focused law firm, announces…
Read More